A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1993
11/25/1993	DE4216756A1 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung 2-arylpropionic acid preparations and methods for their preparation
11/25/1993	DE4216464A1 Use of opt. modified alkali-or ammonium humate(s) - to improve resorbability of hydroxy:apatite bone implants
11/25/1993	DE4216364A1 Pyridyl derivs. with antithrombotic properties
11/25/1993	CA2136312A1 Retroviral protease inhibitors
11/25/1993	CA2136304A1 Inhibitors of testosterone 5.alpha.-reductase activity
11/25/1993	CA2136234A1 Enantiomeric dynemicin analogs, preparation and use thereof
11/25/1993	CA2136213A1 Cultured taxu tissues as a source of taxol, related taxanes and other novel anti-tumor/anti-viral compounds
11/25/1993	CA2136211A1 Novel taxane derivatives, their preparation and compositions containing same
11/25/1993	CA2136196A1 8-substituted anthines as phosphodiesterase inhibitors
11/25/1993	CA2136174A1 Therapeutic uses of pungent botanicals and their related compounds
11/25/1993	CA2136091A1 Chemotherapeutic drug combinations
11/25/1993	CA2136019A1 Use of cotinine to alleviate tobacco withdrawal syndrome
11/25/1993	CA2135928A1 Alcohols as potassium channel openers and in treatment of urinary incontinence
11/25/1993	CA2135784A1 Method for nonspecific cellular immune stimulation
11/25/1993	CA2135646A1 Method and reagent for inhibiting viral replication
11/25/1993	CA2135628A1 Apoptosis inducer
11/25/1993	CA2135612A1 Diamines in the treatment of arrhythmia
11/25/1993	CA2135605A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993	CA2135499A1 Method and reagent for inhibiting cancer development
11/25/1993	CA2135302A1 Agent for treating cataract and method for its preparation
11/25/1993	CA2135211A1 Indazol-3-one-2-yl derivatives of benzopyrans
11/25/1993	CA2135188A1 6-amino substituted imidazo(4,5-b)pyridines as angiotensin ii antagonists
11/25/1993	CA2135174A1 17-ethers and thioethers of 4-aza-steroids
11/25/1993	CA2135173A1 Ester derivatives of 4-aza-steroids
11/25/1993	CA2135167A1 New 17-ester, amide, and ketone derivatives of 3-oxo-4- azasteroids as 5a-reductase inhibitors
11/25/1993	CA2135057A1 17-amino substituted 4-azasteroid 5a-reductase inhibitors
11/25/1993	CA2135056A1 New delta-17 and delta-20 olefinic and saturated 17b-substituted-4-aza-5a-andros-tan-3-ones as 5a-reductase inhibitors
11/25/1993	CA2135055A1 4-azasteroid 5-alpha-reductase inhibitors
11/25/1993	CA2134986A1 Fused imidazole and triazole derivatives as 5-htl receptor agonists
11/25/1993	CA2134765A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties
11/25/1993	CA2134563A1 Substituted pyridines, their preparation and pharmaceutical use
11/25/1993	CA2134200A1 New tricyclic thiazolo and thiazino derivatives and pharmaceutical agents containing them
11/25/1993	CA2133583A1 Antiviral peptides
11/25/1993	CA2131101A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents
11/25/1993	CA2113547A1 Purine derivatives
11/25/1993	CA2113546A1 Novel adenosine derivatives
11/25/1993	CA2113279A1 Use of alpha-ketoglutarate
11/25/1993	CA2112262A1 Agent for increasing somatostatin or for inhibiting decrease of somatostatin
11/24/1993	EP0571338A1 Pharmaceutical oral controlled release composition comprising small pellets of bile acids
11/24/1993	EP0571267A1 Use of azole derivatives for the preparation of drugs useful for inhibiting the aromatase and treating of estrogen-dependent diseases
11/24/1993	EP0571264A1 Autoadhesive matrix system for the transdermal controlled release of piribedil
11/24/1993	EP0571253A1 Benzimidazole derivatives with antidiabetic and antiplatelet aggregation activity
11/24/1993	EP0571243A1 Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them
11/24/1993	EP0571219A2 Esterified propoxylated glycerin fat substitute compositions resistant to gastrointestinal side effects
11/24/1993	EP0571217A2 Novel simethicone containing pharmaceutical compositions for treating gastrointestinal distress
11/24/1993	EP0571202A1 One-pot process for preparing pergolide
11/24/1993	EP0571139A1 Treatment of neurodegenerative diseases
11/24/1993	EP0571063A1 Pharmaceutical preparations
11/24/1993	EP0571012A2 Monoqaternary 2, 16-bispiperidinylandrostane derivatives
11/24/1993	EP0570850A1 Benzo(b)thiophen-3-yl-piperazines, a process for their preparation and their use as medicaments
11/24/1993	EP0570831A2 Use of Xanthinderivatives for treatment of cerebral nerve dammages after disruption of the blood circulation
11/24/1993	EP0570791A2 Low caloric density enteral formulation designed to reduce diarrhoea in tube-fed patients
11/24/1993	EP0570724A1 Salts of 3-(cis-2,6-dimethylpiperidino)-sydnonimine
11/24/1993	EP0570714A2 Aminoalcohols-n-acylderivatives as therapeutical agents against the neurogenic endoneural oedema developing at the peripheral nerve
11/24/1993	EP0570706A1 Aryl and heteroaryl (phosphinylmethyl) phosphonate squalene synthetase inhibitors and method
11/24/1993	EP0570575A1 Bicycloazamacrocyclophosphonic acid, conjugates, contrast agents and preparation
11/24/1993	EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/24/1993	EP0570514A1 Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom
11/24/1993	EP0570507A1 Anti-aggregatory peptides containing an aromatic ester or amide
11/24/1993	EP0570475A1 Pharmaceutical preparation for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances
11/24/1993	EP0570454A1 Novel steroids
11/24/1993	EP0570414A1 Naphthoquinone derivatives for the treatment of chronic inflammation
11/24/1993	EP0570380A1 Novel methylenebisphosphonic acid derivatives
11/24/1993	EP0563301A4 Alteration of rate and character of hair growth
11/24/1993	EP0470995B1 Use of steroidal compounds as anti-fungal agents
11/24/1993	EP0420862B1 Pharmaceutical composition containing deoxyribonucleosides for wound healing
11/24/1993	EP0344184B1 Derivatives of (r) 5-pentylamino-5-oxopentanoic acid with anticholecystokinin activity
11/24/1993	EP0321562B1 Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
11/24/1993	CN1078720A Butadiene derivatives and process for preparing the same
11/24/1993	CN1078633A Medicaments
11/24/1993	CN1022834C Macrolide compounds, their prepn. and use
11/24/1993	CN1022833C 2,3-d,hydro-1-(8-methyl-1,2,4-triazolo-\|4,3-b¨pyridazin-6-yl)-4(1H)-pyridinone
11/24/1993	CN1022832C Preparation of 3-substituted-2-oxindole derivatives
11/24/1993	CN1022831C Preparation of lactone compound
11/24/1993	CN1022830C Preparation of benzamides
11/24/1993	CN1022828C Process for preparation of aryloxy-arylthio-heteroaryloxy-heteroarylthio-alkenylene derivatives of amines
11/23/1993	US5264621 Decanediylbis(carbonylamino)bis(1,5-naphthalenedisulfonic acid for AIDS treatment
11/23/1993	US5264619 Anti-androgenic cyclo and bicyclo alkenes
11/23/1993	US5264618 For transport of biological active agents into cells for viral agents or polynucleotides or immunogenic peptides
11/23/1993	US5264591 Baccatine III derivatives
11/23/1993	US5264578 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
11/23/1993	US5264576 Pyrazolo[4,3-c]pyridines which are intermediates
11/23/1993	US5264459 Use of β-adrenergic agonists to treat patients with demyelinating or autoimmune diseases
11/23/1993	US5264454 Certain 2-oxo-tetrahydro-cycloalkyl-benzopyran-3yl ureas having acyl-CoA-cholesterol acyl transferase inhibitory activity
11/23/1993	US5264451 Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones
11/23/1993	US5264449 N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidinone
11/23/1993	US5264443 Psychotropic drugs, antidepressants and anxiolytic agents
11/23/1993	US5264441 Anticholesterol agents
11/23/1993	US5264438 Dopamine receptor agonists
11/23/1993	US5264437 Antiinflammatory agents, immunosuppressants or antiallergens
11/23/1993	US5264431 Inhibitors for proteinkinase C
11/23/1993	US5264430 Enzyme inhibitor, antiinflammatory agents, treats emphysema, cystic fibrosis and arthritis
11/23/1993	US5264429 Enzyme inhibitor, antiinflammatory agents, treats emphysema, cystic fibrosis and arthritis
11/23/1993	US5264428 Treatment of prostrate cancer
11/23/1993	US5264425 Glycosaminoglycan salts and pharmaceutical compositions containing them
11/23/1993	US5264424 Modified gangliosides and the functional derivatives thereof
11/23/1993	US5264417 Dosing an effective amount of bicozamycin ester derivatives
11/23/1993	US5264356 Regulating retroviral replication, infection, and pathogenesis
11/23/1993	US5264222 Colloidal bismuth subcitrate, reduced absorption
11/23/1993	US5264220 Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents

1 ... 7150 7151 7152 7153 7154 7155 7156 7157 7158 7159 7160 7161 7162 7163 7164 7165 7166 7167 7168 7169 7170 ... 7860